Omnicell (OMCL) Amortizatization of Intangibles (2019 - 2026)
Omnicell's (OMCL) quarterly Amortizatization of Intangibles came in at $1.9 million in Q2 2026, down 7.09% year-over-year from $2.1 million in Q2 2025, and down 0.78% quarter-over-quarter from $1.9 million in Q1 2026.
Analysis
Omnicell (OMCL) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Amortizatization of Intangibles for 8 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 7.09% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a 3.28% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 4.2% from the prior year.
- Amortizatization of Intangibles was $1.9 million for Q2 2026 at Omnicell, down from $1.9 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.3 million in Q1 2022 and troughed at $1.4 million in Q3 2024.
- A 5-year average of $2.1 million and a median of $2.0 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles sank 46.58% in 2022 and jumped 42.35% in 2025, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $2.5 million in 2022, then retreated by 20.88% to $2.0 million in 2023, then grew by 12.14% to $2.2 million in 2024, then slipped by 12.17% to $2.0 million in 2025, then slipped by 2.94% to $1.9 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.9 million (Q2 2026), $1.9 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 10.34 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 1.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.01 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.53 Mn |
| Mar 31, 2022 | 3.31 Mn |
| Dec 31, 2021 | 4.73 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 4.62 Mn |
| Mar 31, 2021 | 4.57 Mn |